Bio-Techne Corp (FRA:TE1)
€ 69 1 (1.46%) Market Cap: 11.07 Bil Enterprise Value: 11.27 Bil PE Ratio: 80.74 PB Ratio: 5.63 GF Score: 95/100

Bio-Techne Corp at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 04:30PM GMT
Release Date Price: €72.5 (-5.23%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Good afternoon. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandy Couillard, I cover life science tools diagnostics sector. Very happy to have Bio-Techne with us back at the conference this year and here to share an update with us, Mr. Jim Hippel, CFO. Jim.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

All right. Thank you, Brandon, for having us. Really appreciate it. Start off very quickly here our tagline, we're science intersects innovation, but it's much more than just a tagline. It really is at the core of what we do as a company. Our employees are all about innovation and innovating to bring science forward -- move science forward to help our customers essentially create new cures and diagnostics to help patients.

So that's really at the core of what our company is all about. Now I'm sorry, I forgot to ask about the clicker. Do I hit. I'm sure you get the right button. Sorry, Brandon, which -- what do I use for a clicker here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot